Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality

被引:526
|
作者
Suissa, Samy [1 ,2 ,3 ]
Dell'Aniello, Sophie [1 ]
Ernst, Pierre [1 ,4 ]
机构
[1] McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ H3T 1E2, Canada
[3] McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada
[4] McGill Univ, Jewish Gen Hosp, Div Pulm, Montreal, PQ H3T 1E2, Canada
基金
加拿大健康研究院;
关键词
INHALED CORTICOSTEROID USE; AIR-FLOW OBSTRUCTION; COPD EXACERBATIONS; RISK; PREVENTION; GLUCOCORTICOIDS; HOSPITALIZATION; METAANALYSIS; SALMETEROL; MANAGEMENT;
D O I
10.1136/thoraxjnl-2011-201518
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background The long-term natural history of chronic obstructive pulmonary disease (COPD) in terms of successive severe exacerbations and mortality is unknown. Methods The authors formed an inception cohort of patients from their first ever hospitalisation for COPD during 1990-2005, using the healthcare databases from the province of Quebec, Canada. Patients were followed until death or 31 March 2007, and all COPD hospitalisations occurring during follow-up were identified. The hazard functions of successive hospitalised COPD exacerbations and all-cause mortality over time were estimated, and HRs adjusted for age, sex, calendar time and comorbidity. Results The cohort included 73 106 patients hospitalised for the first time for COPD, of whom 50 580 died during the 17-year follow-up, with 50% and 75% mortality at 3.6 and 7.7 years respectively. The median time from the first to the second hospitalised exacerbation was around 5 years and decreased to <4 months from the 9th to the 10th. The risk of the subsequent severe exacerbation was increased threefold after the second severe exacerbation and 24-fold after the 10th, relative to the first. Mortality after a severe exacerbation peaked to 40 deaths per 10 000 per day in the first week after admission, dropping gradually to 5 after 3 months. Conclusions The course of COPD involves a rapid decline in health status after the second severe exacerbation and high mortality in the weeks following every severe exacerbation. Two strategic targets for COPD management should include delaying the second severe exacerbation and improving treatment of severe exacerbations to reduce their excessive early mortality.
引用
收藏
页码:957 / 963
页数:7
相关论文
共 50 条
  • [1] Chronic obstructive pulmonary disease exacerbations and their impact on the long-term natural history of the disease
    Dusser, Daniel
    [J]. PRESSE MEDICALE, 2008, 37 (11): : 1599 - 1603
  • [2] Long-Term Azithromycin Therapy To Reduce Acute Exacerbations In Patients With Severe Chronic Obstructive Pulmonary Disease
    Naderi, N.
    Joubert, A.
    Mostafavi-Pour-Manshadi, S. -M. -Y.
    Ouellet, I.
    Drouin, I.
    Li, P. Zhi
    Assayag, D.
    Bourbeau, J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [3] Long-term azithromycin therapy to reduce acute exacerbations in patients with severe chronic obstructive pulmonary disease
    Naderi, Nafiseh
    Assayag, Deborah
    Mostafavi-Pour-Manshadi, Seyed-Mohammad-Yousof
    Kaddaha, Zeina
    Joubert, Alexandre
    Ouellet, Isabelle
    Drouin, Isabelle
    Li, Pei Zhi
    Bourbeau, Jean
    [J]. RESPIRATORY MEDICINE, 2018, 138 : 129 - 136
  • [4] Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
    Soler-Cataluña, JJ
    Martínez-García, MA
    Sánchez, PR
    Salcedo, E
    Navarro, M
    Ochando, R
    [J]. THORAX, 2005, 60 (11) : 925 - 931
  • [5] Long-Term Natural History of Severe Asthma Exacerbations and Their Impact on the Disease Course
    Lee, Tae Yoon
    Petkau, John
    Sadatsafavi, Mohsen
    [J]. ANNALS OF THE AMERICAN THORACIC SOCIETY, 2022, 19 (06) : 907 - 915
  • [6] The role played by exacerbations in the natural history of chronic obstructive pulmonary disease
    Soler Cataluna, Juan Jose
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2007, 43 (02): : 55 - 58
  • [7] Natural history of exacerbations in patients with chronic obstructive pulmonary disease.
    Donaldson, GC
    Seemungal, TAR
    Wedzicha, JA
    [J]. THORAX, 2000, 55 : A3 - A3
  • [8] Long-term Erythromycin Therapy Is Associated with Decreased Chronic Obstructive Pulmonary Disease Exacerbations
    Seemungal, Terence A. R.
    Wilkinson, Tom M. A.
    Hurst, John R.
    Perera, Wayomi R.
    Sapsford, Ray J.
    Wedzicha, Jadwiga A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 178 (11) : 1139 - 1147
  • [9] Trajectories of Severe Exacerbations of Chronic Obstructive Pulmonary Disease and Their Relationship with Mortality Risk
    Rafael Golpe
    Juan Marco Figueira-Gonçalves
    Carlos Antonio Amado-Diago
    Andrea Expósito-Marrero
    Laura González-Ramos
    David Dacal-Rivas
    Ignacio García-Talavera
    Cristóbal Esteban
    [J]. Lung, 2022, 200 : 601 - 607
  • [10] Trajectories of Severe Exacerbations of Chronic Obstructive Pulmonary Disease and Their Relationship with Mortality Risk
    Golpe, Rafael
    Figueira-Goncalves, Juan Marco
    Amado-Diago, Carlos Antonio
    Exposito-Marrero, Andrea
    Gonzalez-Ramos, Laura
    Dacal-Rivas, David
    Garcia-Talavera, Ignacio
    Esteban, Cristobal
    [J]. LUNG, 2022, 200 (05) : 601 - 607